Johnson & Johnson’s Dividend Machine Is Running. Can Earnings Keep Up? - Yahoo Finance
Johnson & Johnson’s Dividend Machine Is Running. Can Earnings Keep Up? Yahoo Finance
Johnson & Johnson Company News
Johnson & Johnson (JNJ) Stock Looks Reasonable As Crohns Drug Data Lands - Simply Wall Street
Johnson & Johnson (JNJ) Stock Looks Reasonable As Crohns Drug Data Lands Simply Wall Street
2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) - The Motley Fool
2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going) The Motley Fool
Johnson & Johnson to Showcase the Future of Surgical Intelligence at Abu Dhabi Future Health Summit 2026 - Business Wire
Johnson & Johnson to Showcase the Future of Surgical Intelligence at Abu Dhabi Future Health Summit 2026 Business Wire
Johnson and Johnson Earnings Report | 2026 Q3 Infographic - Johnson & Johnson
Johnson and Johnson Earnings Report | 2026 Q3 Infographic Johnson & Johnson
J&J Is Leaning Toward Spinning Out Its Hips-And-Knees Business - WSJ
J&J Is Leaning Toward Spinning Out Its Hips-And-Knees Business WSJ
Lawsuit accuses Essity, Edgewell, J&J of violating PFAS ban in California - Manufacturing Dive
Lawsuit accuses Essity, Edgewell, J&J of violating PFAS ban in California Manufacturing Dive
Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half - Rutland Herald
Johnson & Johnson Launches Next-Generation Shockwave™ C2 Aero Fly Coronary IVL Catheter, Cutting IVL Treatment Time in Half Rutland Herald
Johnson & Johnson Stock Could Be a Defensive Play for the Years Ahead - 24/7 Wall St.
Johnson & Johnson Stock Could Be a Defensive Play for the Years Ahead 24/7 Wall St.
Johnson & Johnson reports mixed Q3 earnings - Healthcare Brew
Johnson & Johnson reports mixed Q3 earnings Healthcare Brew
Johnson & Johnson CFO taps internal investment for medtech growth - CFO Dive
Johnson & Johnson CFO taps internal investment for medtech growth CFO Dive
Johnson & Johnson CFO Joseph Wolk on the company’s Q3 results - CNBC
Johnson & Johnson CFO Joseph Wolk on the company’s Q3 results CNBC
Johnson & Johnson (JNJ) Debuts New Coronary Catheter In The U.S. - Yahoo Finance
Johnson & Johnson (JNJ) Debuts New Coronary Catheter In The U.S. Yahoo Finance
Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy. - The Motley Fool
Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy. The Motley Fool
Has Johnson & Johnson Stock Become A Different Bet? - Yahoo Finance
Has Johnson & Johnson Stock Become A Different Bet? Yahoo Finance
The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services - Yahoo Finance
The Zacks Analyst Blog Highlights Abbott Laboratories, Johnson & Johnson, Stryker, Waste Management and Republic Services Yahoo Finance
Johnson & Johnson stock falls despite strong earnings as investors focus on medtech unit - Yahoo Finance
Johnson & Johnson stock falls despite strong earnings as investors focus on medtech unit Yahoo Finance
What Does Johnson & Johnson (JNJ) News Mean For Its Growth Case? - Simply Wall Street
What Does Johnson & Johnson (JNJ) News Mean For Its Growth Case? Simply Wall Street
J&J posts weak medical device sales, shares fall - CNBC
J&J posts weak medical device sales, shares fall CNBC
Johnson & Johnson's Enterprise Review Expected to Sharpen Outlook, Morgan Stanley Says - Yahoo Finance
Johnson & Johnson's Enterprise Review Expected to Sharpen Outlook, Morgan Stanley Says Yahoo Finance
J&J’s medtech business slows again in Q3 - MedTech Dive
J&J’s medtech business slows again in Q3 MedTech Dive
Johnson &Johnson Stock Earnings: Can a Spinoff Fix Its Medtech Problem - Barron's
Johnson &Johnson Stock Earnings: Can a Spinoff Fix Its Medtech Problem Barron's
Should You Invest in This Dividend King on the Dip? - The Motley Fool
Should You Invest in This Dividend King on the Dip? The Motley Fool
Who Owns Tylenol? Kenvue, Johnson & Johnson and the Brand's History - HowStuffWorks
Who Owns Tylenol? Kenvue, Johnson & Johnson and the Brand's History HowStuffWorks
Johnson & Johnson Reports 48-Week Tremfya Results in Phase 3 Crohn’s Disease Fistula Study - Yahoo
Johnson & Johnson Reports 48-Week Tremfya Results in Phase 3 Crohn’s Disease Fistula Study Yahoo
Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool
Johnson & Johnson Beats Third-Quarter Earnings Estimates and Raises 2026 Revenue and Profit Outlook - Yahoo Finance
Johnson & Johnson Beats Third-Quarter Earnings Estimates and Raises 2026 Revenue and Profit Outlook Yahoo Finance
Johnson & Johnson's Upgraded Full-Year Outlook Misses Wall Street Views; Stock Declines - Yahoo Finance
Johnson & Johnson's Upgraded Full-Year Outlook Misses Wall Street Views; Stock Declines Yahoo Finance
Johnson & Johnson raises profit guidance in Q3 2026 earnings - Quartz
Johnson & Johnson raises profit guidance in Q3 2026 earnings Quartz
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance - Business Wire
Johnson & Johnson reports Q3 2026 results, raises 2026 guidance Business Wire
Johnson & Johnson stock slides despite company's projected $100 billion annual sales - Fox Business
Johnson & Johnson stock slides despite company's projected $100 billion annual sales Fox Business
TD Cowen reiterates Johnson & Johnson stock rating on Shockwave growth By Investing.com - Investing.com India
TD Cowen reiterates Johnson & Johnson stock rating on Shockwave growth By Investing.com Investing.com India
Why Johnson & Johnson Stock Dropped Today - The Motley Fool
Why Johnson & Johnson Stock Dropped Today The Motley Fool
Johnson & Johnson Reports Q3 2026 Results, Raises Full-Year Guidance - VisionMonday.com
Johnson & Johnson Reports Q3 2026 Results, Raises Full-Year Guidance VisionMonday.com
Johnson & Johnson leaning toward spinning out hips-and-knees business - WSJ (JNJ:NYSE) - Seeking Alpha
Johnson & Johnson leaning toward spinning out hips-and-knees business - WSJ (JNJ:NYSE) Seeking Alpha
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026 - Business Wire
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2026 Business Wire
Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect - The Motley Fool
Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect The Motley Fool
Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect - Yahoo Finance
Prediction: Johnson & Johnson Will Be a Faster-Growing Company by 2030 Than Most Investors Expect Yahoo Finance
UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings? - Yahoo Finance
UnitedHealth vs. Johnson & Johnson: Which Stock Is the Better Buy After Q3 Earnings? Yahoo Finance
Johnson & Johnson: Keep Calm And Hold On (NYSE:JNJ) - Seeking Alpha
Johnson & Johnson: Keep Calm And Hold On (NYSE:JNJ) Seeking Alpha